Does prostate magnetic resonance imaging (MRI) reporting system affect performance of MRI in men with a clinical suspicion of prostate cancer?

BJU Int. 2020 Jan;125(1):4-5. doi: 10.1111/bju.14960.

Authors

Ivan Jambor^{1

2

3}, Ugo Falagario^{4

5}

Affiliations

¹ Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
² Department of Radiology, University of Turku, Turku, Finland.
³ Medical Imaging Centre of Southwest Finland, Turku University Hospital, Turku, Finland.
⁴ Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁵ Department of Urology and Organ Transplantation, University of Foggia, Foggia, Italy.

PMID: 31901008
DOI: 10.1111/bju.14960

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Image-Guided Biopsy
Magnetic Resonance Imaging
Male
Prostate-Specific Antigen
Prostatic Neoplasms*

Substances

Prostate-Specific Antigen